Navigation Links
Cancer Care Compromised by Cost

A team of researchers has recommended that, in order to implement better cancer care to patients certain reforms have to be mustered immediately. //Their views were published in the British Medical journal. The team of researchers opined that the National Institute for Health and Clinical Excellence (NICE) should amend some of their modes of action, in order to cater to the immediate needs of cancer patients. More planning is essential to ensure that those battling with cancer shall be assured supply of life saving drugs through the NHS.

Last August NICE, had pointed that unless local Trusts mobilized funds, they would be unable to cover the entire costs of drugs like Herceptin to patients. Herceptin is a drug that can fight cancer by targeting a protein, the HER2 protein, which can trigger off tumors. Almost 20% of breast cancers are noted to be HER2 positive. NICE has ruled that, all breast cancer patients that are HER2 would benefit from treatment with Herpecitin following chemotherapy, surgery or radiation therapy. However following this ruling, no move has been made by NICE to indicate where the extra funds should be recovered from. Unless federal funds are released, cancer patient who cannot afford the treatment cannot get the benefits.

Doctors from Norwich University Hospital NHS Trust studied the data linked to the bulk of cancer patients receiving treatment at their hospital. Their findings show that 1.9 million pounds are required to make the drug Herpecitin available to all patients who need the drug. Costs cannot be contained with the treatment alone. The projected expense can be covered only if the equally important palliative care or chemotherapy is done away with, they concluded.

There is no conclusive data that shows that there are any long term benefits that the drug Herpecetin, promises except that it is the drug of choice at this moment. That is not a reliable reason to deny patients conventional treatment and sw itch over to Herpecitin, which is not cost effective either, say doctors.

Doctors who were part of the study opine that, in an ideal situation the government should back up their decision by providing the source of funding for newer drugs. Suggestions have been framed, urging the Department of Health to keep aside money to fund NICE.
MST
'"/>




Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Consensus on "Combination Therapy" for Breast Cancer
6. Cancers of Colon & Rectum linked to Cigarette Smoking
7. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
8. The Cancer Rumour mill working over time
9. Cancer drugs in development nearly doubled since 1995
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. Cancer patients turning to Internet for information
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/23/2017)... ... January 23, 2017 , ... ... gynecological care and gynecological services for women of all ages. The ... a wide variety of reproductive services from routine health screenings to diagnosing and ...
(Date:1/23/2017)... ... ... “Crossing the Bar”: a moving and eloquent drama depicting the events ... is the creation of published author, Charlotte Hotte, a North Carolina native, a mother ... of the book to her sister, Denise, wishes to acknowledge her savior, Jesus Christ, ...
(Date:1/23/2017)... ... January 23, 2017 , ... “Life Under Blankets”: an entrancing story about ... “Life Under Blankets” is the creation of published author, Kimberly Mitchell, who earned her ... She went on to pursue a master’s degree in education in the field of ...
(Date:1/23/2017)... ... ... Valentine’s Day is a time when many people celebrate romance and love by giving cards, ... for the ideal present, Atlanta-based Perimeter Plastic Surgery is offering a Valentine’s Day ... $200 and get $50 free. , “A lot of people just buy the more ...
(Date:1/22/2017)... (PRWEB) , ... January 22, 2017 , ... Zifam Pinnacle, ... across the world, recently met with big-name retail buyers at the January ECRM Trade ... of efficacy and uses the utmost safety standards in all of its creations to ...
Breaking Medicine News(10 mins):
(Date:1/21/2017)... -- Faruqi & Faruqi, LLP, a leading national securities law firm, ... KMPH ) of the federal securities class action ... and underwriters of the Company,s April 16, 2015 Initial Public ... The lawsuit has been filed in the ... County on behalf of all those who acquired ...
(Date:1/20/2017)... 2017  Ethicon Endo-Surgery, Inc. announced today ... Inc., a privately held medical device company ... used in operating rooms worldwide. The acquisition ... energy devices with Megadyne,s innovative portfolio of ... in Ethicon,s goal to deliver the most ...
(Date:1/20/2017)... Jan. 20, 2017  Palladian Health, a leading ... the launch of an opioid management program which ... opioids and helps stem the growing tide of ... to treat chronic non-cancer pain (back pain, neck ... and lack of evidence regarding long-term effectiveness. ...
Breaking Medicine Technology: